Absence of Therapeutic Efficacy of the Somatostatin Analogue Lanreotide in Advanced Primary Hepatic Cholangiocellular Cancer and Adenocarcinoma of the Gallbladder Despite In Vivo SomatostatinReceptor Expression

Author： Fiebiger W. C. C.   Scheithauer W.   Traub T.   Kurtaran A.   Gedlicka C.   Kornek G. V.   Virgolini I.   Raderer M.  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.37, Iss.2, 2002-02, pp. : 222-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin and somatostatin receptor physiology

By Barnett Philip  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 255-264

Humana Press, Inc

Access to resources Recommend Favorite

Effect of the Somatostatin Analogue Lanreotide on Meal-Stimulated Portal Blood Flow in Patients with Liver Cirrhosis

By  

Digestion, Vol. 65, Iss. 1, 2002-04 ,pp. : 56-60

Karger

Access to resources Recommend Favorite

In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5

By Gatto Federico  

Pituitary, Vol. 14, Iss. 2, 2011-06 ,pp. : 141-147

Springer Publishing Company

Access to resources Recommend Favorite

Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland

By Deghenghi Romano   Papotti Mauro   Ghigo Ezio   Muccioli Giampiero   Locatelli Vittorio  

Endocrine Journal, Vol. 14, Iss. 1, 2001-02 ,pp. : 29-33

Humana Press, Inc

Access to resources Recommend Favorite

Somatostatin and Its Receptor Family

By Patel Y.C.  

Frontiers in Neuroendocrinology, Vol. 20, Iss. 3, 1999-07 ,pp. : 157-198

Elsevier

Access to resources Recommend Favorite